Surgeons are no longer allowed to perform plastic surgery following the death of a wealthy patient during a penis enlargement procedure. Ehud Arye Laniado, a 65-year-old Belgian-Israeli diamond dealer, passed away from a heart attack while undergoing the penis enlargement surgery at the Saint-Honore-Ponthieu aesthetic clinic in Paris. The surgeon, identified as Guy H, specialized in treating affluent clients like Ehud, conducting procedures that cost tens of thousands of euros and occurred two to four times annually.
Ehud, owner of Omega Diamonds, would receive treatment outside of regular office hours, opting for injections to enhance the appearance of his penis. Initially investigated for potential manslaughter charges after his death, the case shifted towards allegations of failing to provide aid to a person in distress, drug-related offenses, and practicing medicine without proper authorization.
Following the incident, a Paris court revoked Guy H’s medical license and sentenced him to 15 months in prison. Another surgeon, who stood in for Guy H on the night of Ehud’s death, received a 12-month suspended sentence. Both practitioners have been permanently barred from practicing medicine and were ordered to pay fines of €50,000 and €20,000, respectively.
Reports indicate that the cause of death was not linked to the injection into the penis, raising concerns about the surgeon’s delayed calls for assistance during the medical emergency. The defense initially claimed that Ehud’s behavior and insistence on the injections, despite complaining of abdominal pain, prompted the first call for help. However, the subsequent heart attack was unexpected due to the patient’s preexisting ulcer condition, which diverted attention from a potential cardiac issue.
Although the circumstances surrounding the death were alarming, an unnamed Parisian medical professional mentioned that such incidents were not uncommon in the realm of cosmetic surgery, particularly in establishments that prioritize reputation and techniques over adherence to regulations. This case, while tragic, highlights the challenges present in high-end cosmetic surgery practices that often operate beyond conventional boundaries.